Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic identification of non-canonical transcription factor motifs. | BMC Mol Cell Biol | 2021 | 34465294 | PubTator, text mining | PubMed |
| Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. | Signal Transduct Target Ther | 2021 | 34446699 | PubTator, text mining | PubMed |
| Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program. | Genome Med | 2021 | 34446064 | PubTator, text mining | PubMed |
| Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity. | Cancers (Basel) | 2021 | 34439162 | PubTator, text mining | PubMed |
| Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate Cancer. | Cancers (Basel) | 2021 | 34439101 | PubTator, text mining | PubMed |
| Novel ETV1 mutation in small cell lung cancer transformation resistant to EGFR tyrosine kinase inhibitors. | Ann Transl Med | 2021 | 34430591 | PubTator, text mining | PubMed |
| Capicua Regulates Dendritic Morphogenesis Through Ets in Hippocampal Neurons in vitro. | Front Neuroanat | 2021 | 34385910 | PubTator, text mining | PubMed |
| ETS1, ELK1, and ETV4 Transcription Factors Regulate Angiopoietin-1 Signaling and the Angiogenic Response in Endothelial Cells. | Front Physiol | 2021 | 34381375 | PubTator, text mining | PubMed |
| Retraction: Transcription activation of microRNA-25 by PEA3 augments progression of gastric cancer through suppressing SIK1. | Exp Physiol | 2021 | 34374476 | PubTator, text mining | PubMed |
A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules. | J Oncol | 2021 | 34367283 | PubTator, text mining | PubMed |
| Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma. | Cancers (Basel) | 2021 | 34359682 | PubTator, text mining | PubMed |
| ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression. | J Biochem | 2021 | 34347084 | PubTator, text mining | PubMed |
| The role of MMP-14 in ovarian cancer: a systematic review. | J Ovarian Res | 2021 | 34344453 | PubTator, text mining | PubMed |
| In vitro monitoring of HTR2A-positive neurons derived from human-induced pluripotent stem cells. | Sci Rep | 2021 | 34326453 | PubTator, text mining | PubMed |
| Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma. | Sci Prog | 2021 | 34315286 | PubTator, text mining | PubMed |
| Src-1 and SP2 promote the proliferation and epithelial-mesenchymal transition of nasopharyngeal carcinoma. | Open Med (Wars) | 2021 | 34307888 | PubTator, text mining | PubMed |
| PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3. | Cell Death Dis | 2021 | 34290239 | PubTator, text mining | PubMed |
| RHOX10 drives mouse spermatogonial stem cell establishment through a transcription factor signaling cascade. | Cell Rep | 2021 | 34289349 | PubTator, text mining | PubMed |
| The Knockdown of ETV4 Inhibits the Papillary Thyroid Cancer Development by Promoting Ferroptosis Upon SLC7A11 Downregulation. | DNA Cell Biol | 2021 | 34283663 | PubTator, text mining | PubMed |
| Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response. | Cancers (Basel) | 2021 | 34283056 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=40